---
title: "Innovative drug concept stocks rise, Staidson BioPharm up over 10%"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/239459125.md"
description: "Innovative drug concept stocks surged, Staidson BioPharm rose over 10%, Hinova rose over 6%, Hotgen, Hengrui Pharma, and TONGHUA GOLDEN-HORSE also saw increases"
datetime: "2025-05-09T01:40:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239459125.md)
  - [en](https://longbridge.com/en/news/239459125.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239459125.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/239459125.md) | [English](https://longbridge.com/en/news/239459125.md)


# Innovative drug concept stocks rise, Staidson BioPharm up over 10%

Innovative drug concept stocks surged, with Staidson BioPharm rising over 10%, Hinova rising over 6%, and Hotgen, Hengrui Pharma, and TONGHUA GOLDEN-HORSE also climbing

### 相關股票

- [Hotgen (688068.CN)](https://longbridge.com/zh-HK/quote/688068.CN.md)
- [Hengrui Pharma (600276.CN)](https://longbridge.com/zh-HK/quote/600276.CN.md)
- [TONGHUA GOLDEN-HORSE (000766.CN)](https://longbridge.com/zh-HK/quote/000766.CN.md)
- [Staidson BioPharm (300204.CN)](https://longbridge.com/zh-HK/quote/300204.CN.md)
- [Hinova (688302.CN)](https://longbridge.com/zh-HK/quote/688302.CN.md)

## 相關資訊與研究

- [Jiangsu Hengrui Pharmaceuticals Co., Ltd. Announces Approval for New Indication of Hetrombopag Olamine Tablets](https://longbridge.com/zh-HK/news/279054278.md)
- [China Shenhua Energy Company Limited Reports Sales Results for the Month and Year to Date Ended February 2026](https://longbridge.com/zh-HK/news/279075190.md)
- [Hengrui Pharmaceuticals Unit Gets Nod to Trial Liver Cancer Treatment](https://longbridge.com/zh-HK/news/278831568.md)
- [Jiangsu Hengrui Pharmaceuticals Gets China Nod for Two Anti-Tumor Injectables](https://longbridge.com/zh-HK/news/278349440.md)
- [Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend](https://longbridge.com/zh-HK/news/279032574.md)